Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/11/2026 | Q4 | $10.4M | -- | -- | -$2.90 | -- |
| 11/06/2025 | Q3 | $10.2M | $11.8M | -$1.87 | -$2.79 | $0.91 |
| 08/07/2025 | Q2 | $9.4M | $11.2M | -$2.95 | -$3.12 | $0.17 |
| 05/08/2025 | Q1 | $15.4M | $10.5M | -$0.24 | -$2.82 | $2.58 |
| 03/12/2025 | Q4 | $36.7M | $29.2M | $0.51 | -$2.93 | $3.43 |
| 11/07/2024 | Q3 | $18.3M | $24.1M | -$0.18 | -$3.09 | $2.92 |
| 08/08/2024 | Q2 | $17.5M | $23.5M | -$0.25 | -$3.01 | $2.76 |
| 05/09/2024 | Q1 | $15.3M | $21.6M | -$0.19 | -$3.08 | $2.89 |
| 03/04/2024 | Q4 | $21.4M | $23.9M | -$0.22 | -$2.94 | $2.72 |
| 11/07/2023 | Q3 | -- | $24.1M | -$0.24 | -- | -- |
| 08/08/2023 | Q2 | -- | $20.5M | -$0.27 | -- | -- |
| 05/09/2023 | Q1 | -- | $21.6M | -$0.73 | -- | -- |
| 02/28/2023 | Q4 | -- | $22M | -$0.32 | -- | -- |
| 11/03/2022 | Q3 | -- | $23.6M | -$0.31 | -- | -- |
| 08/04/2022 | Q2 | -- | $21.6M | -$0.85 | -- | -- |
| 05/05/2022 | Q1 | -- | $24.8M | -$0.49 | -- | -- |
| 02/28/2022 | Q4 | -- | $25M | -$0.79 | -- | -- |
| 11/04/2021 | Q3 | -- | $24.9M | -$0.70 | -- | -- |
| 08/05/2021 | Q2 | -- | $28.3M | -$0.69 | -- | -- |
| 05/06/2021 | Q1 | -- | $23.6M | -$0.68 | -- | -- |
| 02/25/2021 | Q4 | -- | $23.5M | -$0.65 | -- | -- |
| 11/05/2020 | Q3 | -- | $30M | -$0.61 | -- | -- |
| 08/06/2020 | Q2 | -- | $48.8M | -$0.45 | -- | -- |
| 05/07/2020 | Q1 | -- | $50.6M | -$0.78 | -- | -- |
| 02/27/2020 | Q4 | -- | $33.9M | -$0.64 | -- | -- |
| 11/06/2019 | Q3 | -- | $29.2M | -$8.43 | -- | -- |
| 08/08/2019 | Q2 | -- | $23.3M | -$9.48 | -- | -- |
| 05/08/2019 | Q1 | -- | $28.2M | -$10.32 | -- | -- |
| 02/28/2019 | Q4 | -- | $39.8M | -$0.57 | -- | -- |
| 11/07/2018 | Q3 | -- | $27.8M | -$0.56 | -- | -- |
| 08/08/2018 | Q2 | -- | $1.1B | $5.33 | -- | -- |
| 05/10/2018 | Q1 | -- | $38M | -$0.60 | -- | -- |
| 03/01/2018 | Q4 | -- | $95.5M | -$0.21 | -- | -- |
| 11/07/2017 | Q3 | -- | $152.9M | $0.37 | -- | -- |
| 08/08/2017 | Q2 | -- | $34.6M | -$0.39 | -- | -- |
| 05/09/2017 | Q1 | -- | $24.7M | -$0.42 | -- | -- |
| 03/01/2017 | Q4 | -- | $37.5M | -$0.28 | -- | -- |
| 11/03/2016 | Q3 | -- | $36.3M | -$0.32 | -- | -- |
| 08/03/2016 | Q2 | -- | $32.8M | -$0.36 | -- | -- |
| 05/03/2016 | Q1 | -- | $58.9M | -$0.14 | -- | -- |
| 03/01/2016 | Q4 | -- | $39.4M | -$0.40 | -- | -- |
Nektar Therapeutics reported $11.8M worth of top line sales in its most recent quarter.
Nektar Therapeutics announced earnings per share of -$1.87 which represents a beat of analyst forecast a -$2.79 per share.
Nektar Therapeutics reported $11.6M that represents $0.61 per share over the last quarter.
Nektar Therapeutics's earnings are forecast to decrease from -$8.68 per share to -$12.00 per share next year representing a decrease of -4.11%.
Nektar Therapeutics's next earnings date is March 11, 2026.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.